Business
Breakthroughs in Alzheimer’s research may be game-changers - The Philadelphia Inquirer
Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating disease that affects more than 7 million people in the U.S. alone.
By: The Philadelphia Inquirer
- Dec 28 2024
- 0
- 0 Views
Research on Alzheimers disease is approaching a much-needed tipping point. The media spotlight has been on newly available drugs like lecanemab and donanemab that target the protein plaques associate… [+5446 chars]